OACC (Oaktree Acquisition III Life Sciences) Moat Score: 2/10 (As of Jun. 28, 2026)


OACC Oaktree Acquisition Corp III Life Sciences OACC
15 GF Score
Price $10.67
View Full Analysis

What is Oaktree Acquisition III Life Sciences Moat Score?

Oaktree Acquisition III Life Sciences OACC -0.28% 15 Moat Score is 2 as of Jun. 28, 2026. GuruFocus rates OACC with a GF Score™ of 15/100. Among 594 Diversified Financial Services companies, Oaktree Acquisition III Life Sciences ranks better than 96.46% on this metric.

Oaktree Acquisition III Life Sciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Oaktree Acquisition III Life Sciences has No Moat: Oaktree Acquisition Corp III lacks significant market leadership, brand strength, or proprietary technology. The company operates in a highly competitive environment with transient advantages.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Oaktree Acquisition III Life Sciences might have No Moat - Very weak/transient advantages.

Oaktree Acquisition III Life Sciences  (NAS:OACC) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Oaktree Acquisition III Life Sciences Moat Score Related Terms

OACC vs RAAQ, FACT, PLMK: Moat Score Comparison

For the Shell Companies subindustry, Oaktree Acquisition III Life Sciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oaktree Acquisition III Life Sciences Moat Score vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oaktree Acquisition III Life Sciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Oaktree Acquisition III Life Sciences's Moat Score falls into.


OACC
15GF Score
Oaktree Acquisition Corp III Life Sciences OACC
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Oaktree Acquisition III Life Sciences (OACC) has a Moat Score of 2 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Oaktree Acquisition III Life Sciences ranks #21 out of 594 companies in the Diversified Financial Services industry, placing it in the top 3.5%.
Is Oaktree Acquisition III Life Sciences' Moat Score too high?
Oaktree Acquisition III Life Sciences' current Moat Score is 2. Based on the distribution chart, Oaktree Acquisition III Life Sciences ranks #21 out of 594 companies in the Diversified Financial Services industry, which is in the top quartile — a strong position relative to peers. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Oaktree Acquisition III Life Sciences' Moat Score compare to RAAQ and FACT?
According to the Diversified Financial Services industry distribution chart, Oaktree Acquisition III Life Sciences ranks #21 out of 594 companies for Moat Score. This places Oaktree Acquisition III Life Sciences in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Diversified Financial Services company?
A good Moat Score depends on the Diversified Financial Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Oaktree Acquisition III Life Sciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oaktree Acquisition III Life Sciences stock overvalued right now?
Oaktree Acquisition III Life Sciences (OACC) has a current Moat Score of 2. The current Moat Score is 2. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current Moat Score is 2 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oaktree Acquisition III Life Sciences Business Description

Address 333 South Grand Avenue, 28th Floor, Los Angeles, CA, USA, 90071
Oaktree Acquisition Corp III Life Sciences is a blank check company.
15GF Score

Get the complete analysis for OACC

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.67
Price